
From risk to resilience
Peng Fu, CEO, and Estrid Jakobsen, Communications Lead at Conscience, explore how creativity and open science are transforming drug discovery. The traditional drug discovery model is showing signs of strain. The cost of developing new medicines continues to rise while early-stage funding is becoming harder to secure, timelines remain… Read More














